**Frequently Asked Questions**
**What is AtaiBeckley?**
AtaiBeckley is a biopharmaceutical company on a mission to transform patient outcomes by developing rapid-acting, durable, and convenient mental health treatments.
**What is AtaiBeckley’s approach to mental health treatment?**
AtaiBeckley develops patient-first, evidence-based therapies aimed at achieving rapid-acting, durable, and convenient treatments for large-scale patient impact.
**What mental health conditions does AtaiBeckley focus on?**
AtaiBeckley works to transform the treatment paradigm for mental health conditions where people currently have limited options.
**How many people are affected by mental health conditions globally?**
According to the World Health Organization, more than one billion people live with a mental health condition around the world.
**What is the economic impact of mental health conditions?**
The global economic cost of mental health conditions is expected to reach $5 trillion by 2030, according to The Lancet.
**Do most people with mental health conditions receive effective care?**
No, most people living with a mental health condition do not have access to effective care, according to the World Health Organisation.
**What kind of expertise does AtaiBeckley’s team have?**
AtaiBeckley’s diverse team includes drug development, healthcare, and commercialization experts united by a common goal to transform patient outcomes and create breakthroughs in mental health.
**What is AtaiBeckley’s leadership approach?**
AtaiBeckley leads with empathy, backed by deep expertise from their dedicated team of professionals.
Leave a Reply